New York · 2025 Regular Session · Bill
S 9497: Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 9497 is a bill introduced in the New York Senate on March 18, 2026. According to its official title, it concerns: Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug. Primary sponsor: Nathalia Fernández (Democratic). Most recent recorded action (June 1, 2026): SUBSTITUTED BY A1428.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Nathalia Fernández | Primary sponsor | Democratic | Senate | 34 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- SUBSTITUTED BY A1428
- ORDERED TO THIRD READING CAL.1489
- COMMITTEE DISCHARGED AND COMMITTED TO RULES
- REPORTED AND COMMITTED TO FINANCE
- REFERRED TO INSURANCE